Carlo Alfieri: Redefining Anemia Management After Kidney Transplantation
Carlo Alfieri, Editor-in-Chief of GCND, Associate Professor at the University of Milan., shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in GCND, adding:
“I am pleased to share our latest publication in the Journal of Clinical Nephrology and Dialysis:
‘Rethinking Anemia Management After Kidney Transplant’
Post-transplant anemia remains one of the most frequent and clinically relevant complications after kidney transplantation, with important implications for graft function, cardiovascular risk, and patient survival. In this review, we provide an updated overview of its pathophysiology and current therapeutic strategies, with particular attention to the emerging role of HIF-prolyl hydroxylase inhibitors (HIF-PHIs) in the management of kidney transplant recipients.
As editor in chief of the journal, I am committed to promoting high-quality scientific research and stimulating discussion on clinically relevant topics in nephrology and transplantation.
I warmly encourage colleagues to consider GCND for the submission of their original articles, reviews, short communications, and clinical experiences, helping to further strengthen our scientific community.”
Title: From iron to HIF-PH inhibitors: rethinking anemia management after kidney transplant
Authors: Anna De Amici, Chiara De Liso, Anna Pisacreta, Margherita Di Naro, Lara Caldiroli, Paolo Molinari, Anna Regalia, Emilietta Brigati, Simona Verdesca, Marco Maggi, Matteo Tommaso Righi, Michele Filippi, Giuseppe Castellano, Carlo Alfieri

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH